Norges Bank’s Intersect ENT, Inc XENT Stock Holding History

Norges Bank’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-243,000	Closed	-$6.81M	–	2220
2022 Q1	$6.81M	Hold	243,000	–	–	﹤0.01%	1807
2021 Q4	$6.64M	Hold	243,000	–	–	﹤0.01%	1864
2021 Q3	$6.61M	Buy	+243,000	New	+$6.01M	﹤0.01%	1874
2020 Q4	–	Sell	-56,700	Closed	-$925K	–	2190
2020 Q3	$925K	Buy	+56,700	New	+$1.03M	﹤0.01%	2039

Norges Bank's XENT Position: Q2 2022 in Review

Norges Bank sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 243,000 shares — an estimated $6.81M sold.

Norges Bank first reported a position in XENT in Q3 2020 and held it in 4 quarters. The position peaked at $6.81M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

Norges Bank reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
Norges Bank sold 243,000 Intersect ENT, Inc shares in Q2 2022, an estimated $6.81M.
Norges Bank first reported a position in Intersect ENT, Inc in Q3 2020 and held it in 4 quarters.
Norges Bank's Intersect ENT, Inc position peaked at $6.81M in Q1 2022.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Norges Bank's 13F filing for Q2 2022, filed 11 Aug 2022.